Shah Capital Management Novavax Inc Transaction History
Shah Capital Management
- $215 Million
- Q1 2025
A detailed history of Shah Capital Management transactions in Novavax Inc stock. As of the latest transaction made, Shah Capital Management holds 11,131,846 shares of NVAX stock, worth $77.9 Million. This represents 33.15% of its overall portfolio holdings.
Number of Shares
11,131,846
Previous 11,148,846
0.15%
Holding current value
$77.9 Million
Previous $89.6 Million
20.39%
% of portfolio
33.15%
Previous 35.54%
Shares
12 transactions
Others Institutions Holding NVAX
# of Institutions
305Shares Held
90.1MCall Options Held
5.76MPut Options Held
6.65M-
Vanguard Group Inc Valley Forge, PA15.7MShares$110 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$82.9 Million0.0% of portfolio
-
State Street Corp Boston, MA7.04MShares$49.3 Million0.0% of portfolio
-
Coatue Management LLC New York, NY3.84MShares$26.9 Million0.13% of portfolio
-
Geode Capital Management, LLC Boston, MA3.76MShares$26.3 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $548M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...